News

Published on 28 Feb 2024 on Benzinga

ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday - ICU Medical...

Article preview image

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

 

Read the rest of the article
NASDAQ.APLS price evolution
NASDAQ.TARS price evolution
NASDAQ.STRL price evolution
NYSE.ECL price evolution
NASDAQ.ICUI price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91%

Tarsus Pharmaceuticals, Inc. (TARS) closed the last trading session at $35.77, gaining 20.8% over...

Zacks via Yahoo Finance 6 Mar 2024
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) defied analyst predictions to release its full-year re...

Simply Wall St. via Yahoo Finance 1 Mar 2024
Party Time: Brokers Just Made Major Increases To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) shareholders will have a reason to smile today, with t...

Simply Wall St. via Yahoo Finance 29 Feb 2024
Tarsus Pharmaceuticals sets $32 stock offering price

Tarsus Pharmaceuticals, Inc. ( NASDAQ :TARS), a company focusing on the development of treatments...

Investing.com 29 Feb 2024
Tarsus Pharmaceuticals launches $100 million stock offering

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), a company dedicated to addressing unmet medical needs...

Investing.com 28 Feb 2024
Here's Why Tarsus Pharmaceuticals, Inc. (TARS) is a Great Momentum Stock to Buy

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 28 Feb 2024
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2023 Earnings Call Transcript

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2023 Earnings Call Transcript February 27, 2024 Tar...

Insider Monkey via Yahoo Finance 28 Feb 2024
ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday - ICU Medical...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all ana...

Benzinga 28 Feb 2024
Tarsus Pharmaceuticals Inc (TARS) Reports Robust Q4 and Full-Year 2023 Financial Results

Q4 Revenue: $13.1 million from XDEMVY net product sales.Full-Year Revenue: $17.4 million, primari...

GuruFocus.com via Yahoo Finance 27 Feb 2024
When Will Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Turn A Profit?

With the business potentially at an important milestone, we thought we'd take a closer look at Ta...

Simply Wall St. via Yahoo Finance 29 Jan 2024

Copyright Statfolio @ 2024

Social Accounts